Skip to main content
TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
28.08
+0.31 (1.12%)
At close: Aug 15, 2025, 4:00 PM
28.18
+0.10 (0.36%)
After-hours: Aug 15, 2025, 7:44 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Treatments for B-cell Diseases
329.00M
Log In
Log In
Log In
Log In
Upgrade
Novel Treatments for B-cell Diseases Growth
40.80%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
329.00M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
40.80%
Log In
Log In
Log In
Log In
Upgrade